Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

التفاصيل البيبلوغرافية
العنوان: Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study
المؤلفون: Salles, G, Catalano, J, Feugier, P, Offner, Fritz, Bouabdallah, R, Caballero, D, Brice, P, Pedersen, LM, Haioun, C, Belada, D, Delmer, A, Simpson, D, Tilly, H, Leppa, S, Soubeyran, P, Hagenbeek, A, Casasnovas, O, Tanin, I, Ferme, C, Da Silva, MG, Sebban, C, Pettengell, R, Estell, J, Milone, G, Sonnet, A, Lopez-Guillermo, A, Seymour, J, Xerri, L
المصدر: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL ; ISSN: 0390-6078
سنة النشر: 2010
المجموعة: Ghent University Academic Bibliography
مصطلحات موضوعية: Medicine and Health Sciences
نوع الوثيقة: conference object
اللغة: English
العلاقة: https://biblio.ugent.be/publication/2119653Test; http://hdl.handle.net/1854/LU-2119653Test
الإتاحة: https://biblio.ugent.be/publication/2119653Test
http://hdl.handle.net/1854/LU-2119653Test
رقم الانضمام: edsbas.AC3E2DDB
قاعدة البيانات: BASE